HealthEquity Q4 EPS of $0.95 Beats Estimates, Revenue Tops $334M; Guides Higher
HealthEquity posted fiscal Q4 net income of $49.7 million, or $0.58 GAAP and $0.95 adjusted EPS, topping estimates of $0.89 per share on revenue of $334.6 million versus the $332.8 million forecast. It projects full-year EPS of $4.56 to $4.65 and revenue of $1.41 to $1.42 billion.
1. Q4 Financial Results
HealthEquity reported fiscal fourth-quarter net income of $49.7 million, translating to $0.58 per share on a GAAP basis and $0.95 per share adjusted. These results exceeded the consensus EPS estimate of $0.89, with revenue reaching $334.6 million compared to the $332.8 million forecast.
2. Full-Year 2025 Performance
For the fiscal year ending January 2026, the company delivered net profit of $215.2 million, or $2.46 per share, on revenue of $1.31 billion, marking year-over-year growth in both earnings and top-line sales.
3. Fiscal 2026 Outlook
HealthEquity provided guidance for the coming fiscal year with expected earnings of $4.56 to $4.65 per share and revenue projected between $1.41 billion and $1.42 billion, indicating confidence in continued growth momentum.